MSI-H Advanced Colorectal Cancer
1 clinical trials · Condition
◉ Watch MSI-H Advanced Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer (NCT05035381) | Tianjin Medical University Cancer Institute and Hospital | 2019-01-01 |
Track MSI-H Advanced Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.